William Harnisch’s Novo Nordisk NVO Stock Holding History

William Harnisch’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50,800	Closed	-$2.44M	–	47
2021 Q3	$2.44M	Buy	+50,800	New	+$2.46M	0.22%	13

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Harnisch's NVO Position: Q4 2021 in Review

William Harnisch sold out of Novo Nordisk (NVO) in Q4 2021, closing a stake of 50,800 shares — an estimated $2.44M sold.

William Harnisch first reported a position in NVO in Q3 2021 and held it in 1 quarter. The position peaked at $2.44M in Q3 2021. 887 funds tracked by Wall St. Rank hold NVO as of Q4 2021.

William Harnisch reported no remaining Novo Nordisk position as of Q4 2021 after selling out during the quarter.
William Harnisch sold 50,800 Novo Nordisk shares in Q4 2021, an estimated $2.44M.
William Harnisch first reported a position in Novo Nordisk in Q3 2021 and held it in 1 quarter.
William Harnisch's Novo Nordisk position peaked at $2.44M in Q3 2021.
887 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2021.

Based on Peconic Partners's 13F filing for Q4 2021, filed 14 Feb 2022.